Content: clearly state the objectives and relevance of your work. Specify succinctly the methodology (particularly the scale of your work, lab, pilot, full scale). Clearly state the results (preferably with numbers, if relevant) and the conclusions. Avoid generalities and vague statements of future results. Avoid the "narrative" type of Abstract. Abstracts with a strong commercial slant or bias will be rejected.
Format: Do not use the title ‘Abstract’. Abstracts may be either in English, Spanish, or Portuguese, and cannot exceed one page. Please use Standard Letter page, with 2.5 cm margins left, right, top, and bottom. Use 12-point Arial or Arial-like font (sans serif).
Write the title in capital (uppercase) letters, bold, and centered.
Leave a blank line before beginning the author list, which also is to be centered.
Use uppercase-lowercase for this list. After each author name write a number between parentheses for identifying the author affiliation. The name of the Corresponding Author should be in bold, and italics.
Leave a blank line before beginning the affiliation list. Use uppercase-lowercase and full justification. Each affiliation should start with the corresponding number between parentheses, name of institution, Dept. or Unit, city, country. Provide complete address and e-mail, telephone and fax numbers only in the affiliation of the Corresponding Author.
Leave a blank line after the affiliation list, and start writing the text of the abstract.
Do not leave blank lines between paragraphs, paragraphs should be indented. Use full justification for the text.
Please prepare the abstract file in Word 97-2003. The name of the abstract should be as follows:
4ISEBE-Last name Initial of the First Name-Abstract
If you are submitting more than one abstract, please add a correlative Arabic number (1, 2, etc.) after the word Abstract in the file name. For instance, two abstracts whose corresponding author is Rafael Hernandez-Vera should be named in this way:
4ISEBE-Hernandez-VeraR-Abstract1
4ISEBE-Hernandez-VeraR-Abstract2
In this example we chose an author with a compounded last name, by purpose, because this is the most common case in Mexico and Latin America.
Please check a Sample Abstract in the web page.
Presentation preference: In a second page after the abstract, please state your preference for presenting the paper, oral (platform) or poster.
Detailed List of authors: In the same second page after the abstract, please include complete address, e-mail, telephone and fax numbers of ALL CO-AUTHORS.
Languages: Official languages of the event are Spanish, English, and Portuguese. If you choose English for your Abstract and articles and the English is not your native language, ask for a review by a native English speaker for correct English syntax, style, and spelling, before sending the Abstract (all grammatical errors will be responsibility of the authors).
Submission: Abstracts must be submitted by e-mail to
4isebe@gmail.com
addressed to
Prof. Elvira Ríos-Leal or Dr. Héctor M. Poggi-Varaldo
CINVESTAV-IPN, Dept. of Biotechnology and Bioengineering, P.O. Box 14-740, Mexico DF, 07000, Mexico.
If you plan to send any document by private carrier, please use the street address as follows:
Dr. Héctor M. Poggi-Varaldo
Department: Biotechnology and Bioengineering
Institution: CINVESTAV-IPN
Street: Av IPN 2508, Col San Pedro Zacatenco
City: Mexico City
State: DF
Zip code: 07360
Country: MEXICO
Telephone: 52(55) 5747-3800 ext. 4324 and ext. 4336
Facsimile: 52(55) 5747-3313
Please include OUR phone and fax numbers on the address label of your shipment, just in case of misrouting by the private courier. Confirm the sending of your shipment to us by e-mail (4isebe@gmail.com) including the airway bill number and name of the private courier.
Receipt of your abstract will be acknowledged by e-mail within five working days.
Deadline for Abstract Submission: the abstracts should be sent BEFORE 15 June 2014.
Review: Abstracts received by the 15 June 2014 deadline will be reviewed for technical merit and relevance. When assigning accepted abstracts to program slots, the Evaluation Committee will consider the authors' suggestions as to the Topic session and presentation preference (oral or poster), but the final decision on placement will be based on best overall design of the Conference program.
Notification of Acceptance/Placement: By the end of June 2014, a letter stating the Committee's decision on each abstract will be mailed and e-mailed to the Corresponding Author. If the Abstract was accepted, this letter will state the oral or poster session to which the abstract has been assigned, and will provide information on preparing the presentation.
Please be aware that in general, multiple presentations by the same and one registered author are not possible. Each different abstract should have a different registered author.